Product Code: BIO247A
Highlights:
The global bioanalytical testing services market reached $2.9 billion in 2022, should reach $3.2 billion by 2023 and $6.6 billion by 2028 with a compound annual growth rate (CAGR) of 15.2% during the forecast period of 2023-2028.
Cell-Based Assays segment of the global bioanalytical testing services market reached $572.5 million in 2022, should reach $653.0 million by 2023 and $1.4 billion by 2028 with a CAGR of 15.7% during the forecast period of 2023-2028.
Bioequivalence & Bioavailability Studies segment of the global bioanalytical testing services market reached $523.6 million in 2022, should reach $597.5 million by 2023 and $1.3 billion by 2028 with a CAGR of 16.3% during the forecast period of 2023-2028.
Report Scope:
The report's scope includes an overview of the global market on bioanalytical testing services and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.
The report analyzes leading services, applications, end user, and product details for the bioanalytical testing services market. Leading market players' profiles, specific services, financial information, and recent market activities are provided. This report also assesses companies' mergers & acquisitions and funding activities and their impact in the face of the competitive environment. The report details the bioanalytical testing services market based on service type, application, and end user. The market is segmented into pharmacokinetics studies, bioequivalence and bioavailability studies, biomarker testing services, cell-based assays, virology testing, method development, optimization & validation, serology, immunogenicity, and neutralizing antibodies, and others.
The market is categorized as oncology, immunology, neurology, infectious diseases, cardiovascular diseases, and others. The market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, contract development and manufacturing organizations, and others. The report also consists of the impact of the COVID-19 pandemic on this market. Regional analysis includes North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the World (South America, and the Middle East and Africa).
Report Includes:
- 45 data tables and 44 additional tables
- An overview of the global market for bioanalytical testing services
- An estimate of market size and analyses of global market trends, with data from 2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Characterization and quantification of the global market for bioanalytical testing services on the basis of technology, application, end user and region
- Information on sample requirements for discovery bioanalysis, preclinical and clinical bioanalysis and descriptions of toxicokinetic and pharmacokinetics studies
- Coverage of technological advances in the drug discovery process and information on investments in the R&D of biologics, biosimilars and other specialty drugs
- An examination of the drivers and constraints that will shape the market, and a discussion of the upcoming market opportunities in order to forecast the market by its segments and sub-segments
- An assessment of existing products as well as those in the pipelines of the major players in the market
- Coverage of recent advances, emerging technologies and ongoing developments in the industry
- An evaluation of key industry acquisitions and strategic alliances, and an analysis of the market shares of the leading companies
- Company profiles of major players within the industry, including SGS S.A., Intertek Group PLC, Eurofins Scientific SE, Charles River International Laboratories, Inc., Inotiv Inc., and WuXi AppTec
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Methodology
- Information Sources
- Geographic Breakdown
Chapter 2 Summary and Highlights
- Market Outlook
- Market Summary
Chapter 3 Market Overview
- Introduction
- Technology Background
- Liquid Chromatography-Mass Spectrometry (LC-MS)
- Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
- Nuclear Magnetic Resonance (NMR)
- Capillary Electrophoresis (CE)
- Gas Chromatography-Mass Spectrometry (GC-MS)
Chapter 4 Market Dynamics
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact of COVID-19 on the Bioanalytical Testing Services Market
- Regulatory Landscape
- PESTEL Analysis
- Success Factors in Pharmaceutical Bioanalysis
- Investing in High Capability Equipment
- Constant Evaluation of the Latest Technologies
- Considering the Impact of Rising Dose Trials on Patient Safety
- Keeping a Track of Changes in Regulatory Environment
Chapter 5 Global Bioanalytical Testing Services Market by Service Type
- Pharmacokinetics Studies
- Bioequivalence and Bioavailability Studies
- Biomarker Testing Services
- Cell-Based Assays
- Virology Testing
- Method Development, Optimization & Validation
- Serology, Immunogenicity, and Neutralizing Antibodies
- Others
Chapter 6 Global Bioanalytical Testing Services Market by Application
- Oncology
- Cardiovascular Diseases
- Immunology
- Neurology
- Infectious Diseases
- Others
Chapter 7 Global Bioanalytical Testing Services Market by End User
- Pharmaceutical and Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Contract Development and Manufacturing Organizations (CDMOs)
- Others
Chapter 8 Global Bioanalytical Testing Services Market by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 9 ESG Developments
- Introduction to ESG
- Importance of ESG in Bioanalytical Testing Services Industry
- ESG Ratings and Metrics: Understanding the Data
- ESG practices in the Bioanalytical Testing Services Industry
- Environmental Performance
- Social Performance
- Governance Performance
- Future Trends
- BCC Research Viewpoint
Chapter 10 Emerging Technologies and Developments
- Emerging Technologies
- Recent Developments in Bioanalytical Sample Preparation Techniques
Chapter 11 M&A Analysis
Chapter 12 Competitive Intelligence
- Top Market Players Ranking, 2022
- Key Strategies Adopted by Companies
- Expansion
- New Product Launch
- Collaboration
- Others
Chapter 13 Company Profiles
- AFFIGENIX BIOSOLUTIONS PVT LTD
- ALMAC GROUP
- ARAGEN LIFE SCIENCES PVT LTD
- BIOANALYTICAL SYSTEMS INC.
- BIONEEDS INDIA PRIVATE LTD
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- EUROFINS SCIENTIFIC SE
- INOTIV INC. (ENVIGO)
- INTERTEK GROUP PLC
- LABORATORY CORP. OF AMERICA HOLDINGS
- PACE ANALYTICAL
- PACIFIC BIOLABS
- SARTORIUS AG
- SGS S.A.
- SYNEOS HEALTH
- WUXI APPTEC CO. LTD